Dermata Therapeutics, Inc.
DRMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,692 | -$1,701 | -$2,304 | -$3,151 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $39 | $37 | $30 |
| Change in WC | -$150 | -$1,029 | $332 | $208 |
| Other Non-Cash | $38 | $0 | $0 | $0 |
| Operating Cash Flow | -$1,804 | -$2,690 | -$1,934 | -$2,914 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$13 | -$548 | $8,492 | -$70 |
| Stock Repurch. | -$0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1 |
| Financing Cash Flow | -$13 | -$548 | $8,492 | -$69 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,817 | -$3,238 | $6,558 | -$2,982 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,481 | $9,719 | $3,162 | $6,144 |
| End Cash | $4,664 | $6,481 | $9,719 | $3,162 |
| Free Cash Flow | -$1,804 | -$2,690 | -$1,934 | -$2,914 |